NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank60
Studio
Year-over-Year Change

Return on equity

Latest
-29.82%
↑ 14% vs avg
Percentile
P60
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
-34.61%
Historical baseline
PeriodValueYoY Change
2025-29.82%+6.5%
2024-31.89%+48.0%
2023-61.35%-1065.8%
2022-5.26%+92.9%
2021-73.79%-1239.3%
2020-5.51%-